Covered on earnings, thin on cash. A 3.54% yield is real, and the dividend was raised to $0.42875 a quarter from $0.425, but cash coverage is thin: fiscal 2025 free cash flow of $82.7 million covered only about a quarter of roughly $343 million of dividends declared. The strain is a capital program, not an earnings shortfall — regulated earnings cover the payout; the build consumes the cash.
Key risk: A heavy capital program — about $1 billion of incremental capital spending added through 2030, $5.4 billion of long-term debt at fiscal 2025 year-end — plus regulatory timing: an Oklahoma rate review filing is due in summer 2026 with new rates in 2027, and regulatory timing already dented fourth-quarter 2025 results.
Changes if: Earnings guidance slips below the $2.38 low end, or the payout stays above 70% while free cash flow stays near zero and the dividend raise shrinks to token size. Earnings coverage, then cash, are the tripwires here.
- !Payout-coverage check: About 73% of fiscal 2025 diluted EPS of $2.32, and about 71% of the 2026 guidance midpoint of $2.43 — covered on earnings, but fiscal 2025 free cash flow of $82.7 million covered only about a quarter of roughly $343 million of dividends declared ($1.6925 per share on about 202 million shares).
- ✓Yield check: 3.54% indicated — $0.42875/qtr × 4 at the $48.41 close on Oct. 23, 2026. Real, recurring yield, not a special.
- ✓Dividend growth check: Raised to $0.42875 a quarter from $0.425 — a 0.9% increase — extending a run of about 19 consecutive years of increases. The raise is small; the direction is intact.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.